Fig. 6From: Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patientsTargeted MS2 of DOX and DOXol in DNA isolated from blood collected from a canine cancer patient (Dog 3) one week after receiving DOXBack to article page